Found: 22
Select item for more details and to access through your institution.
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 3, p. 290, doi. 10.1007/s12185-014-1634-7
- By:
- Publication type:
- Article
Venetoclax in CLL patients who progress after B‐cell Receptor inhibitor treatment: a retrospective multi‐centre Italian experience.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. e8, doi. 10.1111/bjh.16123
- By:
- Publication type:
- Article
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
- By:
- Publication type:
- Article
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130360
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2993, doi. 10.3390/cancers15112993
- By:
- Publication type:
- Article
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3240, doi. 10.3390/cancers13133240
- By:
- Publication type:
- Article
Prospective validation of predictive value of abdominal computed tomography scan on time tofirst treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 1, p. 36, doi. 10.1111/ejh.12545
- By:
- Publication type:
- Article
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 1, p. 72, doi. 10.1111/ejh.12550
- By:
- Publication type:
- Article
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study.
- Published in:
- European Journal of Haematology, 2013, v. 90, n. 6, p. 531, doi. 10.1111/ejh.12096
- By:
- Publication type:
- Article
Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β<sub>2</sub>-microglobulin in B-cell chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 1999, v. 62, n. 2, p. 117, doi. 10.1111/j.1600-0609.1999.tb01731.x
- By:
- Publication type:
- Article
Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 2, p. 91, doi. 10.1159/000521229
- By:
- Publication type:
- Article
Sustained Complete Remission with Incomplete Hematologic Recovery (CRi) in a Patient with Relapsed AML and Concurrent BCR-ABL1 and CBFB Rearrangement Treated with a Combination of Venetoclax and 5-Azacytidine.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 1-2, p. 51, doi. 10.1159/000508658
- By:
- Publication type:
- Article
Sustained Erythroid Response in a Patient with Myelofibrosis Receiving Concomitant Treatment with Ruxolitinib and Deferasirox.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 2, p. 107, doi. 10.1159/000486822
- By:
- Publication type:
- Article
Impact of Arterial Thrombotic Events on the Outcome of Chronic Myeloid Leukemia Patients Treated with Nilotinib First-Line: A GIMEMA CML WP Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S313, doi. 10.1016/j.clml.2017.07.114
- By:
- Publication type:
- Article
The Evolution of Targeted Therapies in Chronic Lymphocytic Leukaemia.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 4, p. 343, doi. 10.1007/s11899-020-00586-1
- By:
- Publication type:
- Article
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 797, doi. 10.1002/ajh.24774
- By:
- Publication type:
- Article
Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E91, doi. 10.1002/ajh.24707
- By:
- Publication type:
- Article
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1090, doi. 10.1002/ajh.24493
- By:
- Publication type:
- Article
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 617, doi. 10.1002/ajh.24362
- By:
- Publication type:
- Article
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 743, doi. 10.1002/ajh.23729
- By:
- Publication type:
- Article
Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.
- Published in:
- 2018
- By:
- Publication type:
- journal article